CD74 and cancer: Regression and KM analyses of prognosis prediction in pan-cancer showed that increased expression of CD74 was associated with prolonged survival in patients with BRCA, CESC, LUAD, MESO, SARC, SKCM, and UCEC, suggestive of a protective role in these cancers.